SCHEMBL23601319

SCHEMBL23601319

CN(c1cccc(Br)c1)c1nc2n[nH]c(=S)n2c2cc(Cl)ccc12

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 5/20 0.36
KDR P35968 1/20 0.36
PDGFRB P09619 3/20 0.36
GRM4 Q14833 1/20 0.35
MAT2A P31153 5/20 0.35
PRMT5 O14744 1/20 0.33
PLK1 P53350 1/20 0.33
ALDH1A1 P00352 3/20 0.33
HSD17B10 Q99714 3/20 0.33
APOBEC3G Q9HC16 3/20 0.33
KDM4E B2RXH2 2/20 0.33
ALOX15 P16050 2/20 0.33
MAPT P10636 2/20 0.33
PKM P14618 1/20 0.33
HPGD P15428 1/20 0.33
ALOX12 P18054 1/20 0.33
MPI P34949 1/20 0.33
NPC1 O15118 1/20 0.32
TSHR P16473 1/20 0.32
MAPK1 P28482 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23576646 0.88 MAT2A (0.39) EGFRKDRPDGFRBGRM4MAT2A
SCHEMBL29909742 0.88 MAT2A (0.39) EGFRKDRPDGFRBGRM4MAT2A
SCHEMBL23601318 0.81 PDGFRB (0.38) EGFRKDRPDGFRBMAT2APRMT5
SCHEMBL23601397 0.81 EGFR (0.38) EGFRKDRPDGFRBMAT2APRMT5
SCHEMBL29909381 0.80 PDGFRB (0.36) EGFRKDRPDGFRBMAT2APRMT5
SCHEMBL23576826 0.80 PDGFRB (0.36) EGFRKDRPDGFRBMAT2APRMT5
SCHEMBL24721479 0.77 PDGFRB (0.35) EGFRKDRPDGFRBMAT2APRMT5
SCHEMBL24806307 0.77 MAPT (0.40) EGFRKDRPDGFRBGRM4MAT2A
SCHEMBL23577196 0.77 PDGFRB (0.38) EGFRKDRPDGFRBMAT2APRMT5
SCHEMBL29909162 0.77 PDGFRB (0.38) EGFRKDRPDGFRBMAT2APRMT5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021130638-A1 DIACYLGLYCEROL KINASE MODULATING COMPOUNDS CARNA BIOSCIENCES, INC. (JP) 2021-07-01 WO disclosed